Obstetrics/Gynecology
RSSArticles
-
Liletta IUD available in the United States
The LILETTA intrauterine device is for sale in the United States. The device was launched through partners Medicines360, a San Francisco-based nonprofit pharmaceutical company, and Actavis, a Dublin, Ireland-based pharmaceutical company.
-
Gay, lesbian, and bisexual youth grouped, show increased risk for unintended pregnancy
The United States has seen significant advances in rights for lesbian and gay populations this summer, with the Supreme Court’s decision affirming same-sex marriage nationwide. As we celebrate this victory, however, we remain aware of the many challenges still facing lesbian, gay, and bisexual populations, including health disparities. Many such disparities affect youth, especially in the areas of sexual and reproductive health.
-
Study: Obese teens less likely to use contraception
A study of nearly 1,000 Michigan teens found that sexually active obese adolescents were significantly less likely to use contraception than normal weight peers.
-
Long-acting reversible contraceptives used by few women after delivery
Researchers recently looked at national data to investigate women’s patterns of contraceptive use after delivery and the association between method use and risk of pregnancy within 18 months.
-
What are the options available for medication prior to IUD placement?
While the American College of Obstetricians and Gynecologists recommends taking over-the-counter pain medication prior to intrauterine device insertion, no specific drug is recommended.
-
Single-size Caya diaphragm is available by prescription in U.S.
The Caya single-size diaphragm, the first new cervical barrier method to enter the market in more than 10 years, is available by prescription from U.S. healthcare providers.
-
Counseling on LARC methods cuts unintended pregnancy rates
Training clinicians to inform women that different birth control methods have very different levels of effectiveness proved key in cutting the number of unintended pregnancies among young women seeking family planning services, data suggests from a new national study from the Bixby Center for Global and Reproductive Health at the University of California, San Francisco.
-
Mammography and the Overdiagnosis of Breast Cancer: What to Do?
A new study reports that the incidence of breast cancer is higher in counties with high rates of mammography screening, but screening is not associated with a decrease in breast-cancer deaths. The decision of whether and how often to perform mammography requires a discussion of the potential consequences of both true positive and false positive screening tests.
-
Vulvar Lichen Sclerosus: How Long Should Women Be Treated?
In this prospective cohort study, women with vulvar lichen sclerosus who were compliant with preventive topical corticosteroids were significantly less likely to develop vulvar intraepithelial neoplasia and squamous cell carcinoma than women who were partially compliant with therapy.
-
Reviewing VTE Risk with Newer Progestins — Journal Watch, We Think You're Wrong
We disagree with a review of a new study on the elevated risk of VTE in users of combined pills. Our abstract & commentary digs deep.